Tilray Brands, Inc. Equity Method Investments
Tilray Brands, Inc. (TLRY) had Equity Method Investments of $0 as of 2024-05-31, per its 10-K filed 2024-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments and Receivables, Net › Long-Term Investments
us-gaap:EquityMethodInvestments · last filed 2024-10-10
- 2024-05-31: Equity Method Investments $0.00.
- 2024-02-29: Equity Method Investments $0.00.
- 2023-11-30: Equity Method Investments $4.64M.
- 2023-08-31: Equity Method Investments $4.64M.
| Period end | Equity Method Investments |
|---|---|
| 2024-05-31 | $0.00 10-K · filed 2024-07-30 |
| 2024-02-29 | $0.00 10-Q · filed 2024-04-09 |
| 2023-11-30 | $4.64M 10-Q · filed 2024-01-09 |
| 2023-08-31 | $4.64M 10-Q · filed 2024-10-10 |
| 2023-05-31 | $4.58M 10-Q · filed 2024-10-10 |
| 2023-02-28 | $4.64M 10-Q · filed 2023-04-10 |
| 2022-11-30 | $4.64M 10-Q · filed 2023-01-09 |
| 2022-08-31 | $4.76M 10-Q · filed 2022-10-07 |
| 2022-05-31 | $4.95M 10-K · filed 2023-07-26 |
| 2022-03-31 | $4.95M 10-Q · filed 2023-01-09 |
| 2021-05-31 | $8.11M 10-K · filed 2021-07-28 |
| 2021-03-31 | $8.10M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $9.30M 10-Q · filed 2021-05-10 |
| 2020-09-30 | $8.91M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $8.74M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $8.83M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $11.45M 10-K · filed 2021-02-19 |
| 2019-09-30 | $12.06M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $6.13M 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |